18503395

Source:http://linkedlifedata.com/resource/pubmed/id/18503395

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0006826, umls-concept:C0087111, umls-concept:C0178602, umls-concept:C0205171, umls-concept:C0220825, umls-concept:C0231441, umls-concept:C0443218, umls-concept:C0740394, umls-concept:C0937932, umls-concept:C2827483
pubmed:issue	6
pubmed:dateCreated	2008-5-27
pubmed:abstractText	To determine the efficacy of a single 7.5-mg dose of rasburicase compared with single doses of 0.15 mg/kg for the prevention or treatment of hyperuricemia associated with tumor lysis syndrome.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8111305
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Urate Oxidase, http://linkedlifedata.com/resource/pubmed/chemical/rasburicase
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0277-0008
pubmed:author	pubmed-author:BestulDaniel JDJ, pubmed-author:ReevesDavid JDJ
pubmed:issnType	Print
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	685-90
pubmed:meshHeading	pubmed-meshheading:18503395-Adult, pubmed-meshheading:18503395-Aged, pubmed-meshheading:18503395-Female, pubmed-meshheading:18503395-Humans, pubmed-meshheading:18503395-Hyperuricemia, pubmed-meshheading:18503395-Male, pubmed-meshheading:18503395-Middle Aged, pubmed-meshheading:18503395-Prospective Studies, pubmed-meshheading:18503395-Tumor Lysis Syndrome, pubmed-meshheading:18503395-Urate Oxidase
pubmed:year	2008
pubmed:articleTitle	Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer.
pubmed:affiliation	Department of Pharmaceutical Services, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.
pubmed:publicationType	Journal Article